Zhongjin Irradiation Incorporated (300962) Fair Value & Analysis

Industrials · CN · Market cap 3.5B CNY

A solid business, but screening 38% overvalued on our models.

What matters now

• The price sits above even our optimistic bull case (¥10.59). The favourable scenario is already priced in.
• Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
• A fairly wide model range (¥5.70 to ¥10.59) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.

How to read this chart

60‑month range ¥10.85 – ¥32.45 · fair‑value band ¥5.70 – ¥10.59 · the ¥13.16 price screens above the ¥8.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 9, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Zhongjin Irradiation Incorporated (300962) currently trades at ¥13.16, while our model-based Fair Value estimate is ¥8.15, implying the stock looks roughly 38.1% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Zhongjin Irradiation Incorporated generated revenue of 365M CNY at a net margin of 31.9%. Revenue grew 0.8% year over year. It earns a return on equity of 11.3%. The balance sheet holds a net cash position of 307M CNY. Fundamentals as of Jul 9, 2026

Our scenario range runs from ¥5.70 (bear case) to ¥10.59 (bull case); at ¥13.16, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 35% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -38%, 300962 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Growth Earnings (¥8.15) versus Earnings-Based (¥2.60). Highest evidence: Residual Income (76).

Key figures & financial health

Quality Score breakdown

About the company

Zhongjin Irradiation Incorporated Company provides irradiation technology services in China. It offers irradiation sterilization services for medical and health care products, food, medicines, daily necessities, packaging materials, and other products; irradiation modification services for polymer materials; scientific and sterilization technology …

Full company description

Zhongjin Irradiation Incorporated Company provides irradiation technology services in China. It offers irradiation sterilization services for medical and health care products, food, medicines, daily necessities, packaging materials, and other products; irradiation modification services for polymer materials; scientific and sterilization technology solutions; and disinfection and sterilization services for reusable diagnostic and treatment equipment, instruments, nursing kits, and surgical kits. The company also provides technical testing services, such as testing, verification and consulting services for irradiation technology services. Zhongjin Irradiation Incorporated Company was incorporated in 2003 and is based in Shenzhen, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Zhongjin Irradiation Incorporated reported revenue of ¥364M in FY2025 versus ¥309M in FY2021, a compound +4.2%/yr. Reported net income was ¥119M in FY2025, compounding +8.0%/yr from FY2021.

300962 screens 38% overvalued. Compare with GE Vernova Inc →

Peer Group

Specialty Industrial Machinery · 809 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Specialty Industrial Machinery median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).

Explore undervalued stocks

More undervalued Industrials stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.